Malinowska B, Schlicker E
Institut für Pharmakologie und Toxikologie, Rheinische Friedrich-Wilhelms-Universität Bonn, Federal Republic of Germany.
Naunyn Schmiedebergs Arch Pharmacol. 1993 Jan;347(1):55-60. doi: 10.1007/BF00168772.
In pithed and vagotomized rats the effects of the H3 receptor agonist R-(-)-alpha-methylhistamine, the H1 receptor agonist 2-(2-thiazolyl)ethylamine and the H2 receptor agonist dimaprit on basal diastolic blood pressure, basal heart rate and the electrically induced rise in heart rate were examined. Basal diastolic blood pressure was not altered by low, but increased by high doses of R-(-)-alpha-methylhistamine; the latter effect was not affected by selective H1, H2 or H3 receptor antagonists and by prazosin, but was attenuated by rauwolscine. Rauwolscine also unmasked a vasodepressor response to R-(-)-alpha-methylhistamine not affected by the H3 receptor antagonist thioperamide, but counteracted by the H1 receptor antagonist dimetindene or the H2 receptor antagonist ranitidine. The vasodepressor responses to 2-(2-thiazolyl)ethylamine and dimaprit were antagonized by dimetindene and ranitidine, respectively. The vasodepressor response to 2-(2-thiazolyl)ethylamine was not altered by indomethacin, but reduced by an inhibitor of endothelial nitric oxide synthase, N omega-nitro-L-arginine methyl ester (which, by itself, markedly increased blood pressure). Both drug tools did not alter the effect of dimaprit. Basal heart rate was not affected by 2-(2-thiazolyl)ethylamine (examined after administration of propranolol), dimaprit and R-(-)-alpha-methylhistamine. The electrically induced increase in heart rate (studied in animals which had received rauwolscine) was decreased by R-(-)-alpha-methylhistamine but not affected by 2-(2-thiazolyl)ethylamine and dimaprit. The effect of R-(-)-alpha-methylhistamine was abolished by thioperamide. R-(-)-alpha-methylhistamine did not influence the increase in heart rate produced by isoprenaline.(ABSTRACT TRUNCATED AT 250 WORDS)
在脊髓横断和迷走神经切断的大鼠中,研究了H3受体激动剂R-(-)-α-甲基组胺、H1受体激动剂2-(2-噻唑基)乙胺和H2受体激动剂二甲双胍对基础舒张压、基础心率以及电刺激引起的心率升高的影响。低剂量的R-(-)-α-甲基组胺不改变基础舒张压,但高剂量时会使其升高;后一种作用不受选择性H1、H2或H3受体拮抗剂以及哌唑嗪的影响,但会被萝芙木碱减弱。萝芙木碱还揭示了R-(-)-α-甲基组胺的血管降压反应,该反应不受H3受体拮抗剂硫代哌啶的影响,但会被H1受体拮抗剂二甲茚定或H2受体拮抗剂雷尼替丁抵消。对2-(2-噻唑基)乙胺和二甲双胍的血管降压反应分别被二甲茚定和雷尼替丁拮抗。对2-(2-噻唑基)乙胺的血管降压反应不受吲哚美辛的影响,但会被内皮型一氧化氮合酶抑制剂Nω-硝基-L-精氨酸甲酯降低(该抑制剂本身会显著升高血压)。这两种药物工具均未改变二甲双胍的作用。基础心率不受2-(2-噻唑基)乙胺(在给予普萘洛尔后检测)、二甲双胍和R-(-)-α-甲基组胺的影响。电刺激引起的心率升高(在接受萝芙木碱的动物中研究)被R-(-)-α-甲基组胺降低,但不受2-(2-噻唑基)乙胺和二甲双胍的影响。硫代哌啶消除了R-(-)-α-甲基组胺的作用。R-(-)-α-甲基组胺不影响异丙肾上腺素引起的心率升高。(摘要截短于250字)